Psoriatic Arthritis and Psoriasis Treatment Decision Aid

University of Pennsylvania37 enrolled

Overview

The purpose of this study is to create and test a patient decision aid that facilitates the shared decision-making process when patients with psoriasis and/or psoriatic arthritis are starting or switching to a new therapy.

Prior to the interventional study, we will develop a decision aid using design thinking. In this interventional study, we will implement and test a patient-centered decision aid for therapy selection among patients with psoriasis and/or psoriatic arthritis who are starting or switching to a new medication.

Study Type

INTERVENTIONAL

Allocation

Purpose

OTHER

Masking

NONE

Enrollment

Conditions

Psoriatic Arthritis Psoriasis

Interventions

Decision AidOTHER

Participants will test decision aid prototypes that are designed to assist them in choosing a medication.

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: 1. Age 18 years or older 2. Diagnosis of psoriasis (as confirmed by dermatologist) or psoriatic arthritis (as confirmed by rheumatologist) 3. Treated at Penn In addition to the above, for the observation and implementation phases of the study: 4. Initiation of a new psoriasis or psoriatic arthritis treatment * Biosimilars that have been approved by the FDA and available on the US market will similarly be eligible for participation * Patients may be taking other traditional DMARDs. * A washout period is not required. Exclusion Criteria: 1. Unable to give informed consent 2. Youth, under the age of 18 years 3. Patients without psoriasis or psoriatic arthritis 4. Not being treated at a Penn clinic In addition to the above, for the observation and implementation phases of the study: 5. Not starting or switching to a new medication

Locations (1)

Hospital at the University of Pennsylvania

Philadelphia, Pennsylvania, United States

Outcomes

Primary Outcomes

Patient and provider self-reported perceptions of the decision aid as measured by satisfaction survey

Satisfaction survey to rate the decision aid and shared decision-making process

Time frame: Up to 24 months

Secondary Outcomes

Number of times decision aid was used in consultation for patients switching therapies or starting a new treatment.

Rates of of the decision aid use

Time frame: Up to 24 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.